Elemento Pharma Limited

Elemento Pharma Limited was established in 2019 in Laos. It is a pharmaceutical company that produces anti-tumor, antiviral, and daily drugs. The company produces a wide range of medications including Capmatinib, Sotorasib, Molnupiravir, Favipiravir, Lorlatinib, Cabozantinib, Dacomtinib, Crizotinib, Lenvatinib, Talazoparib, Apalutamide, and Selpercatinib. It is committed to becoming a world-renowned pharmaceutical company and has expanded its sales business worldwide, exporting hundreds of pharmaceutical products to more than 120 countries and regions. Elemento Pharma has world-class pharmaceutical equipment, advanced facilities, and complies with international quality standards. The company also provides contracted production services.